Tasman Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TASMAN PHARMA, and what generic alternatives to TASMAN PHARMA drugs are available?
TASMAN PHARMA has two approved drugs.
There is one US patent protecting TASMAN PHARMA drugs.
There are six patent family members on TASMAN PHARMA drugs in six countries.
Drugs and US Patents for Tasman Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tasman Pharma | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | OINTMENT;TOPICAL | 215186-001 | Feb 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | 8,057,811 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Tasman Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2005007168 | ⤷ Sign Up |
Australia | 2004257556 | ⤷ Sign Up |
Canada | 2532648 | ⤷ Sign Up |
New Zealand | 527142 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.